| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 11,360 | 12,900 | 03.08. |
| Repligen Corporation: Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media | Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market by adding BioLife's differentiated, high-margin recurring revenue business BioLife... ► Artikel lesen |
| BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2026 Financial Results | Total revenue of $27.5 million, up 25% over Q1 2025
GAAP gross margin and non-GAAP adjusted gross margin of 64%
GAAP net income of $1.2 million and non-GAAP adjusted... ► Artikel lesen |
| BioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations | Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue of $96.2 million, up 29% year-over-year
GAAP... ► Artikel lesen |